MEDPLUS HEALTH SERVICES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 700 INR | -0.39% |
|
+0.51% | -6.55% |
| Sales 2024 * | 56.68B 682M | Sales 2025 * | 68.72B 827M | Capitalization | 84.02B 1.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 518M 6.23M | Net income 2025 * | 1.14B 13.68M | EV / Sales 2024 * | 1.45 x |
| Net cash position 2024 * | 2.01B 24.21M | Net cash position 2025 * | 1.47B 17.66M | EV / Sales 2025 * | 1.2 x |
| P/E ratio 2024 * |
161
x | P/E ratio 2025 * |
73.8
x | Employees | 19,626 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.46% |
More Fundamentals
* Assessed data
More news
Latest transcript on MedPlus Health Services Limited
More recommendations
| 1 day | -1.61% | ||
| 1 week | +0.90% | ||
| Current month | +0.85% | ||
| 1 month | +4.07% | ||
| 3 months | +0.14% | ||
| 6 months | -12.94% | ||
| Current year | -6.39% |
1 week
692.10
720.90
1 month
656.00728.20
Current year
598.60756.60
1 year
598.60978.00
3 years
548.251 343.00
5 years
548.251 343.00
10 years
548.251 343.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 56 | 05-12-31 | |
| Director of Finance/CFO | - | 22-11-10 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Madhavan Ganesan
BRD | Director/Board Member | 59 | 21-06-10 |
| Founder | 56 | 05-12-31 | |
| Chief Operating Officer | - | 07-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 34 M€ | +4.49% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 700 | -0.39% | 103 654 |
| 24-05-28 | 702.8 | -1.61% | 119,660 |
| 24-05-27 | 714.3 | +1.81% | 98,555 |
| 24-05-24 | 701.6 | -1.93% | 46,164 |
| 24-05-23 | 715.4 | +2.49% | 76,346 |
Delayed Quote NSE India S.E., May 28, 2024 at 07:43 am EDT
More quotes
MedPlus Health Services Limited is an India-based omni channel retail pharmacy. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The Company operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.
Sector
Drug Retailers
Calendar
2024-05-28
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
702.8
INR
Average target price
878.4
INR
Spread / Average Target
+24.99%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.39% | 1.03B | |
| -41.10% | 13.83B | |
| -26.34% | 11.5B | |
| +14.31% | 6.41B | |
| -20.28% | 6.32B | |
| -11.33% | 5.97B | |
| +72.00% | 5B | |
| -3.36% | 4.63B | |
| -6.07% | 3.96B | |
| -18.47% | 3.24B |
- Stock Market
- Equities
- MEDPLUS Stock
